Position in SRPT
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$3,417,894
+$1,699,290 QoQ
Shares Held
190,200
+140.8% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#65
of 323 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Jun 30, 2025CallValue
$342,000
CallShares
20,000
PutValue
$769,500
PutShares
45,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. SRPT ranks #26 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,357,042 | $110,693,915 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $80,947,193 | |
| 3 | IMTX |
Immatics N.V.
|
6,506,802 | $65,913,904 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
2,010,534 | $62,849,292 | |
| 5 | CGON |
CG Oncology, Inc.
|
769,947 | $54,704,734 | |
| 6 | ARGX |
Argenx SE
|
45,068 | $41,812,738 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
929,626 | $31,040,212 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
466,258 | $26,679,282 |
All Filings in SRPT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,417,894 | 190,200 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $1,718,604 | 78,980 | Shares | Defined | 2026-05-08 | |
| 2025-06-30 | $342,000 | 20,000 | Call | Defined | 2025-08-12 | |
| 2025-06-30 | $18,262 | 1,068 | Shares | Defined | 2025-08-12 | |
| 2025-06-30 | $769,500 | 45,000 | Put | Defined | 2025-08-12 | |
| 2024-03-31 | $1,009,788 | 7,800 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $482,150 | 5,000 | Call | Defined | 2024-05-06 | |
| 2023-12-31 | $6,338,633 | 65,733 | Shares | Defined | 2024-05-06 | |
| 2023-12-31 | $356,791 | 3,700 | Put | Defined | 2024-05-06 | |
| 2023-09-30 | $2,084,984 | 17,200 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $606,100 | 5,000 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $572,600 | 5,000 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $1,969,744 | 17,200 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $400,132 | 3,494 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $958,883 | 6,957 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $5,058,361 | 36,700 | Put | Defined | 2023-05-15 | |
| 2023-03-31 | $3,101,175 | 22,500 | Call | Defined | 2023-05-15 | |
| 2022-12-31 | $8,487,490 | 65,500 | Call | Defined | 2023-09-21 | |
| 2022-12-31 | $17,817,250 | 137,500 | Put | Defined | 2023-09-21 | |
| 2022-12-31 | $8,978,857 | 69,292 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||